Mechanistic Analysis of T Cell Polarity by Photoactivation of Single Cells
单细胞光活化 T 细胞极性的机制分析
基本信息
- 批准号:8019098
- 负责人:
- 金额:$ 43.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-15 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerolAddressAntigen-Presenting CellsAutoimmunityBehaviorBiochemicalCancerousCell PolarityCell physiologyCellsCommunicationComplexCoupledCytoskeletonDataDevelopmentDiacylglycerol KinaseDiglyceridesDynein ATPaseEnvironmentEventFamilyFluorescence Resonance Energy TransferFoundationsFutureGoalsHealthHumanHuman ResourcesImageImage AnalysisImmune responseIn VitroInfectious AgentKnockout MiceKnowledgeLaboratoriesLeukocytesLinkMalignant NeoplasmsMediatingMicrotubule-Organizing CenterMicrotubulesMissionModificationMolecularMotorNaturePhosphorylationPhysiologicalPlayPositioning AttributeProcessProtein IsoformsProtein Kinase CProteinsReceptor ActivationReceptor SignalingRecruitment ActivityRegulationRelative (related person)ResearchResolutionRoleScientistShapesSignal TransductionSignaling MoleculeSmall Interfering RNASystemT-Cell Immunologic SpecificityT-Cell ReceptorT-LymphocyteTestingTherapeuticTissuesUnited States National Institutes of HealthWorkbasecellular imagingcytokinecytotoxicdynactinfluorescence imagingimmunological synapseimmunological synapse formationin vivoinnovationinsightkillingsloss of functionmembermultidisciplinarynovelphotoactivationpreventpublic health relevanceresearch studyresponsesmall molecule
项目摘要
DESCRIPTION (provided by applicant): T lymphocytes play a central role in protective immune responses against infectious agents and cancer, but their activity must be tightly controlled in order to prevent autoimmunity. This control is thought to be achieved, in part, by the polarization of the T cell's microtubule (MT) cytoskeleton. Specifically, upon recognition of an antigen-presenting cell (APC), the MT organizing center (MTOC) of the T cell reorients to a position just beneath T cell-APC interface, which is also called the immunological synapse (IS). This enables the T cell to secrete cytokines or cytotoxic factors directionally toward the APC, thereby limiting the scope of cytokine- mediated communication or cytotoxic killing, respectively. The long-term goal of our work is to identify the molecular mechanisms that control MT polarity in T cells and to determine the importance of MT polarity for T cell function in vivo. Recent studies have shown that MTOC polarization toward the APC is mediated by the MT motor protein dynein, which is recruited to the IS by the localized accumulation of diacylglycerol (DAG). Precisely how DAG accumulation is established and how it is coupled to dynein recruitment, however, remain unclear. To address these issues, single cell imaging and functional approaches will be used to test two related hypotheses: first, that diacylglycerol kinases (DGKs) and members of the novel protein kinase C (nPKC) family are required for the stable accumulation of DAG and for subsequent MTOC reorientation; and second, that nPKC activity is coupled to dynein by phosphorylation of Marcksl1, a PKC substrate that interacts with the regulatory dynactin complex. The following specific aims will be pursued: 1) Identify and characterize the nPKC isoforms that are required for stable DAG accumulation and reorientation of the MTOC; 2) Determine the roles played by DGK-1 and DGK-6 in shaping the polarizing DAG gradient; and 3) Determine the importance of Marcksl1 dynamics during MTOC reorientation. For the first aim, loss-of-function experiments will be combined with fluorescence imaging to determine which nPKC isoform(s) are involved in the polarization response. For the second aim, DGK-1 and DGK-6 knockout mice will be used to characterize the specific role of each DGK isoform during MTOC reorientation. For the third aim, imaging studies will be combined with biochemical approaches to determine whether Marcksl1 regulates polarity through association with the dynactin complex. This work will rely upon an innovative photoactivation system that enables high- resolution imaging analysis of MTOC polarization and associated signaling events. This research is important because it will identify molecules and signaling events that are required specifically for MTOC polarization in T cells. This knowledge will provide a foundation for future studies aimed at deciphering the role of T cell MT polarity in vivo, and it will also contribute to the development of strategies to modulate T cell polarity selectively in physiological or therapeutic contexts. Hence, it is relevant to the NIH mission in that it will contribute to the advancement of basic knowledge that could aid in the improvement of human health.
PUBLIC HEALTH RELEVANCE: T lymphocytes are crucial for effective immune responses against infectious agents and cancer. Key to their function is the ability to orient themselves toward infected or cancerous target cells, which allows them to selectively eliminate these cells without harming healthy bystander tissue. This proposal seeks to determine how this polarization process takes place in T cells, which could contribute to strategies for controlling T cell polarity and function in therapeutic contexts.
描述(由申请人提供):T淋巴细胞在针对感染因子和癌症的保护性免疫应答中发挥核心作用,但必须严格控制其活性以防止自身免疫。这种控制被认为部分地通过T细胞微管(MT)细胞骨架的极化来实现。具体而言,在识别抗原呈递细胞(APC)时,T细胞的MT组织中心(MTOC)重新定向到T细胞-APC界面下方的位置,其也称为免疫突触(IS)。这使得T细胞能够向APC定向分泌细胞因子或细胞毒性因子,从而分别限制细胞因子介导的通讯或细胞毒性杀伤的范围。我们工作的长期目标是确定控制T细胞中MT极性的分子机制,并确定MT极性对体内T细胞功能的重要性。最近的研究表明,MTOC向APC的极化是由MT运动蛋白动力蛋白介导的,动力蛋白通过二酰基甘油(DAG)的局部积累被招募到IS。然而,确切地说,DAG的积累是如何建立的,以及它是如何与动力蛋白的募集相结合的,仍然不清楚。为了解决这些问题,单细胞成像和功能的方法将被用来测试两个相关的假设:第一,二酰基甘油激酶(DGK)和新的蛋白激酶C(nPKC)家族的成员是必需的DAG的稳定积累和随后的MTOC重定向;第二,nPKC活性通过Marcks 11的磷酸化与动力蛋白偶联,Marcks 11是一种与调节性动力蛋白复合物相互作用的PKC底物。将追求以下具体目标:1)鉴定和表征稳定DAG积累和MTOC重定向所需的nPKC亚型; 2)确定DGK-1和DGK-6在形成极化DAG梯度中所起的作用; 3)确定MTOC重定向期间Marcksl 1动力学的重要性。对于第一个目标,功能丧失实验将与荧光成像相结合,以确定哪些nPKC亚型参与偏振响应。对于第二个目的,DGK-1和DGK-6敲除小鼠将用于表征MTOC重定向期间每种DGK同种型的特定作用。对于第三个目标,成像研究将与生物化学方法相结合,以确定Marcksl 1是否通过与dynactin复合物的关联来调节极性。这项工作将依赖于一个创新的光活化系统,使高分辨率成像分析的MTOC偏振和相关的信号事件。这项研究很重要,因为它将确定T细胞中MTOC极化所需的分子和信号事件。这些知识将为未来的研究提供基础,旨在破译T细胞MT极性在体内的作用,它也将有助于发展战略,以调节T细胞极性选择性在生理或治疗环境。因此,它与国家卫生研究院的使命有关,因为它将有助于促进有助于改善人类健康的基本知识。
公共卫生相关性:T淋巴细胞对于有效的免疫反应至关重要,可以对抗传染性病原体和癌症。它们功能的关键是能够将自己定位于受感染或癌性靶细胞,这使它们能够选择性地消除这些细胞而不伤害健康的旁观者组织。该提案旨在确定这种极化过程如何在T细胞中发生,这可能有助于在治疗背景下控制T细胞极性和功能的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Morgan A Huse其他文献
Morgan A Huse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Morgan A Huse', 18)}}的其他基金
Architectural regulation of cytotoxic synapse detachment
细胞毒性突触脱离的结构调节
- 批准号:
10579319 - 财政年份:2022
- 资助金额:
$ 43.47万 - 项目类别:
Architectural regulation of cytotoxic synapse detachment
细胞毒性突触脱离的结构调节
- 批准号:
10467438 - 财政年份:2022
- 资助金额:
$ 43.47万 - 项目类别:
Mechanoregulation of cytotoxic lymphocyte function
细胞毒性淋巴细胞功能的机械调节
- 批准号:
10316830 - 财政年份:2010
- 资助金额:
$ 43.47万 - 项目类别:
Mechanistic Analysis of T Cell Polarity by Photoactivation of Single Cells
单细胞光活化 T 细胞极性的机制分析
- 批准号:
8214512 - 财政年份:2010
- 资助金额:
$ 43.47万 - 项目类别:
Mechanoregulation of cytotoxic lymphocyte function
细胞毒性淋巴细胞功能的机械调节
- 批准号:
10646310 - 财政年份:2010
- 资助金额:
$ 43.47万 - 项目类别:
Synaptic Control of Cytotoxic T cell Function
细胞毒性 T 细胞功能的突触控制
- 批准号:
9187404 - 财政年份:2010
- 资助金额:
$ 43.47万 - 项目类别:
Mechanistic Analysis of T Cell Polarity by Photoactivation of Single Cells
单细胞光活化 T 细胞极性的机制分析
- 批准号:
8604669 - 财政年份:2010
- 资助金额:
$ 43.47万 - 项目类别:
Mechanistic Analysis of T Cell Polarity by Photoactivation of Single Cells
单细胞光活化 T 细胞极性的机制分析
- 批准号:
7861930 - 财政年份:2010
- 资助金额:
$ 43.47万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 43.47万 - 项目类别:
Research Grant